One could surmise that other cancer types exhibit different levels of dependence on the PI3K/AKT pathway compared to their reliance on other cancer-dysregulated signaling pathways, and depending on the genomic background of those cancers, they may be differentially influenced by the presence of multiple PIK3CAmut. The gene discussed is AKT1; the disease is cancer.